Mflotas-DX Eye Drop BAK Free
128,00 ₹
Аналоги Mflotas-DX Eye Drop BAK Free
Найдите более доступные аналоги и дженерики для Mflotas-DX Eye Drop BAK Free.
Активный ингредиент: Moxifloxacin (0.5% w/v); Dexamethasone (0.1% w/v)
Описание товара
About Mflotas-DX Eye Drop BAK Free
Mflotas-DX Eye Drop BAK Free is a medication containing the active ingredient Moxifloxacin, classified as Antibiotic. Moxifloxacin, sold under the brand name Avelox among others, is an antibiotic, used to treat bacterial infections, including pneumonia, conjunctivitis, endocarditis, tuberculosis, and sinusitis. It can be given by mouth, by injection into a vein, and as an eye drop.
Key Benefits & Uses
- Used for: 1 INDICATIONS AND USAGE Moxifloxacin tablets are a fluoroquinolone antibacterial indicated for treating infections in adults 18 years of age and.
- Used for: 1 ) Skin and Skin Structure Infections: Uncomplicated ( 1
- Use only as directed on the product label or by a healthcare professional.
Active Ingredient & Action
Moxifloxacin, the active ingredient in Mflotas-DX Eye Drop BAK Free, belongs to the Antibiotic class. 1 INDICATIONS AND USAGE Moxifloxacin tablets are a fluoroquinolone antibacterial indicated for treating infections in adults 18 years of age and older caused by designated susceptible bacteria, in the conditions listed below: Community Acquired Pneumonia ( 1. 1 ) Skin and Skin Structure Infections: Uncomplicated ( 1. Inactive ingredients: not listed in source data.
Important Notes
Always read and follow the label instructions carefully before taking Mflotas-DX Eye Drop BAK Free. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Mflotas-DX Eye Drop BAK Free for extended periods without medical advice.
Найти в аптеках
Сравните местные цены и расстояние для Mflotas-DX Eye Drop BAK Free.
Оценки посетителей
Помогите другим — оцените полезность этой страницы.
Оценок пока нет — будьте первым.